Taiwan's self-produced high-end vaccine recently announced that it can effectively fight against BA.5, and the outside world questioned whether it would pave the way for the DPP authorities to purchase in the future. Xue Ruiyuan, head of the health department of the DPP authority, said yesterday (6) that there will be no high-end in the procurement of next-generation vaccines. However, after November this year, it is estimated that up to 1.7 million doses of high-end vaccines will be scrapped due to expiration. The Kuomintang "legislator" Lin Defu said yesterday that the DPP authorities purchased about 5 million doses of high-end vaccines, which is equivalent to 34% of the total destruction. Calculated at the purchase price of a single dose of more than 800 yuan ( New Taiwan dollars , the same below), there are more than a dozen 100 million yuan of people's tax money is "released".
The "Financial Committee" of the Taiwanese government's legislative body yesterday requested the health authorities and other units to submit a special report on "the purchase, brand, price, dose, administration and related budget implementation and benefits of the new crown vaccine and the cold chain."
According to the "Audit Department" report, as of the end of September this year, Taiwan has purchased more than 68.41 million doses of vaccines, received more than 24.26 million doses of vaccines, a total of more than 92.67 million doses, more than 65.95 million doses have arrived, and 57.87 million doses have been used. remaining dose.
Xue Ruiyuan confirmed that at the end of September, 4 million doses of vaccines were destroyed due to expiration, accounting for 6% of the total number of vaccines. Among the 4 million doses, 1.2 million doses are high-end, and the conversion ratio is 30%. There are more than 500,000 doses valid until November. If they are all destroyed, the maximum dose is 1.7 million doses.
Kuomintang "legislator" Hong Mengkai said that the validity period of high-end vaccines has been extended three times from the earliest 6 months, which is equivalent to extending the period to 12 months, but up to one-third of them have been destroyed. Compared with the overall vaccine rejection rate of 6%, it is nearly 6 times, and the rejection rate is mostly contributed by high-end vaccines.
Hong Mengkai also criticized that more than 3,000 subjects of the high-end vaccine have not yet entered the experiment of the third supplementary dose. The health authorities have made the high-end one of the third supplementary vaccine list with the emergency use authorization (EUA), which is simply a waste of life and the public is regarded as a white rat.
Lin Defu said that high-end vaccines have not passed the international phase III clinical certification, and the Japanese government does not recognize that if people go to Japan, they need to do PCR nucleic acid at their own expense. view?
Xue Ruiyuan argued that the procurement of vaccines is already ahead, and it would be better to let everyone have a surplus after the fight. High-end vaccines have been poorly pumped, and deliveries have been delayed. According to the report submitted by the "Audit Department", " CDC " has calculated and fined daily overdue liquidated damages, but has not yet deducted liquidated damages for the overdue part of more than 30 days and the failure to perform the contract.
"command center" spokesman Zhuang Renxiang said that in March this year, a total of 2% of the liquidated damages had been fined for the non-performance part. As for the relevant amount, he said that there is no way to tell, so as not to expose the unit price of the vaccine.
Recently, the number of confirmed cases of BA.5 variant strains in Taiwan has climbed, and the "command center" encourages the public to use the next-generation vaccine. Kuomintang "legislator" Lai Shibao questioned whether the announcement of high-end vaccines can effectively fight against BA.5. Will it pave the way for the DPP authorities to purchase in the future? Xue Ruiyuan said that "we will wait until the experiment is done", emphasizing that there is no high-end vaccine in the procurement of next-generation vaccines. (Jingxian Lin/Editor)
